Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06098339 · ClinicalTrials.gov registry record · NA
Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers
A NA study of Myopia and Hyperopia, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 3
- Study locations
NCT06098339: Completed NA study of Myopia and Hyperopia, sponsored by CooperVision.
NCT06098339 is a NA study of Myopia and Hyperopia that has completed, run by CooperVision. The registered enrollment target is 53 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (80% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06098339, a NA study of Myopia and Hyperopia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study was to compare the clinical performance of two different reusable lenses in habitual spherical soft lens wearers.
Primary Outcome
Participants measured subjective lens handling at removal on a 0-100 integer scale, where 0=worst and 100=best. Results for each lens were collected in the at-home diary on Day 27.
Interventions
- DEVICE Lens A (fanfilcon A)
- DEVICE Lens B (lotrafilcon B)
Study Locations (3)
Florida
- Coan Eye Care - Ocoee
Pennsylvania
- Nittany Eye Associates - State College
Ontario
- Insight Eye Care - Waterloo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2023-11-13 |
| Est. Completion | 2024-04-04 |
| Phase | NA |
What the finished NCT06098339 record still lists
NCT06098339 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Lens A (fanfilcon A) is the first listed.
NCT06098339 reports a single indexed study location in Florida, Pennsylvania, Ontario.
Frequently Asked Questions
What is clinical trial NCT06098339 about?
NCT06098339 is a clinical study titled "Performance Evaluation of Reusable Contact Lenses When Worn For One Month By Habitual Soft Contact Lens Wearers". The purpose of this study was to compare the clinical performance of two different reusable lenses in habitual spherical soft lens wearers.
What is the current status of trial NCT06098339?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2023-11-13. Estimated completion is 2024-04-04.
What conditions does trial NCT06098339 study?
This clinical trial studies the following conditions: Myopia, Hyperopia.
What interventions are being tested in trial NCT06098339?
The interventions under investigation include: Lens A (fanfilcon A) (DEVICE), Lens B (lotrafilcon B) (DEVICE).
Who is sponsoring clinical trial NCT06098339?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06098339 being conducted?
This trial has 3 study locations across Florida, Pennsylvania, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06098339's enrollment target sits among peer trials
53 64th of 90 higher than 27 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI